Cynthia M Valerio
Cynthia M Valerio is an expert in Endocrinology at Instituto Estadual de Diabetes e Endocrinologia Luiz Capriglione (Brazil). Cynthia M Valerio has authored 45 publications, the most recent in 2026. SLR score: 168 (community average: 125). How the SLR is computed.
LeadR Profile
Endocrinology
Subspecialties: Cardiology - Internal Medicine - Hepatology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Short Biography
Dr. Cynthia Valério is a Brazilian endocrinologist at the forefront of obesity and metabolic medicine in Latin America. As President-Elect of ABESO, Director of FLASO, and Vice Coordinator of the Obesity Department at SBEM, she plays a central role in shaping clinical guidelines and advancing the field across the region. She leads clinical trials at the State Institute of Diabetes and Endocrinology (IEDE-RJ) and is currently pursuing her Ph.D. in Clinical Medicine at the Federal University of Rio de Janeiro (UFRJ), with research spanning obesity, diabetes, dyslipidemia, and lipodystrophies
Organizations
Career arc: 2007 - 2026
Number : 45
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Vitamin B12 replacement strategies: a Brazilian delphi consensus. PMID 42830915 — serum, vitamins, bariatric surgery, vitamin b 12 | EClinicalMedicine | 2026 | 0 |
| Unraveling the natural history of lipodystrophy syndromes: insights from the prospective LD-Lync study. PMID 42524106 — diabetes mellitus, registries, comorbidity, insulin resistance, natural history, leptin, lipodystrophy, hypertriglyceridemia, pancreatitis, history | J Endocr Soc | 2026 | 0 |
| Weight stigma in Latin America and the Caribbean: regional evidence and a call to action by ABESO. PMID 42482695 — obesity, education | Lancet Reg Health Am | 2026 | 1 |
| Safety of very low LDL-cholesterol: Ten common concerns, misconceptions, and evidence-based clarifications. PMID 42242022 — diabetes mellitus, cholesterol, ldl, safety, muscles, neoplasms, cognitive dysfunction, signs and symptoms, cholesterol, therapeutics, cataract | Atherosclerosis | 2026 | 1 |
| Assessment of bone density and microarchitecture in patients with familial partial lipodystrophy. PMID 42158918 — diabetes mellitus, lipodystrophy, familial partial, insulin resistance, lipodystrophy, diagnosis, bone density, diabetes mellitus, type 2 | Front Endocrinol (Lausanne) | 2026 | 0 |
LeadR Networks
Main global connection map